These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31182312)

  • 21. Differential expression of STAT3 gene and its regulatory long non-coding RNAs, namely lnc-DC and THRIL, in two eastern Iranian ethnicities with multiple sclerosis.
    Pahlevan Kakhki M; Rakhshi N; Emami Aleagha MS; Abdari M; Alikhah A; Safarian G; Behmanesh M; Nikravesh A
    Neurol Sci; 2020 Mar; 41(3):561-568. PubMed ID: 31713760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
    Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of multiple sclerosis in Iran: a systematic review.
    Etemadifar M; Sajjadi S; Nasr Z; Firoozeei TS; Abtahi SH; Akbari M; Fereidan-Esfahani M
    Eur Neurol; 2013; 70(5-6):356-63. PubMed ID: 24192707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and prevalence of multiple sclerosis in southeastern Iran.
    Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
    Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of consanguineous marriages among Iranian Georgians.
    Rafiee L; Saadat M
    J Biosoc Sci; 2011 Jan; 43(1):47-50. PubMed ID: 20584350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of multiple sclerosis in Belo Horizonte, Brazil.
    Lana-Peixoto MA; Frota ER; Campos GB; Monteiro LP;
    Arq Neuropsiquiatr; 2012 Feb; 70(2):102-7. PubMed ID: 22311213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
    Etemadifar M; Maghzi AH
    Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.
    Moghbeli M
    Cell Mol Neurobiol; 2020 Jan; 40(1):65-85. PubMed ID: 31482432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020).
    Razazian N; Eskandarieh S; Siabani S; Afshari D; Sahraian MA; Khezri O; Rezaei M; Fakhri N
    Mult Scler Relat Disord; 2022 Jan; 57():103441. PubMed ID: 34896874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018.
    Salehi Z; Almasi-Hashiani A; Sahraian MA; Eskandarieh S
    Mult Scler Relat Disord; 2020 Aug; 43():102178. PubMed ID: 32417663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated.
    Kahana E; Zilber N; Abramson JH; Biton V; Leibowitz Y; Abramsky O
    J Neurol; 1994 Mar; 241(5):341-6. PubMed ID: 8006689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated prevalence and incidence of multiple sclerosis in Iran.
    Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
    Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.
    Zahednasab H; Mesbah-Namin SA; Sahraian MA; Balood M; Doosti R
    Neurosci Lett; 2013 Jun; 545():46-9. PubMed ID: 23618653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
    Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
    Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India.
    Wadia NH; Bhatia K
    Ann Neurol; 1990 Aug; 28(2):177-9. PubMed ID: 2221846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran?
    Pakdel M; Karin Hedström A; Bidkhori M; Hadei M; Kazemi Moghaddam V; Sarmadi M; Zohdi S; Marufi N
    Acta Neurol Scand; 2019 Nov; 140(5):328-335. PubMed ID: 31291697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consanguinity and multiple sclerosis susceptibility: A case control study.
    Maghzi H; Shaygannejad V; Minagar A; Hassanzadeh A; Maghzi AH
    Mult Scler Relat Disord; 2016 Nov; 10():179-180. PubMed ID: 27919486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway.
    Berg-Hansen P; Smestad C; Sandvik L; Harbo HF; Celius EG
    Eur J Neurol; 2013 Dec; 20(12):1546-52. PubMed ID: 23834430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric multiple sclerosis and its familial recurrence: A population based study (1999-2017).
    Eskandarieh S; Sahraiain MA; Molazadeh N; Moghadasi AN
    Mult Scler Relat Disord; 2019 Nov; 36():101377. PubMed ID: 31473489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.